NCT04592887: Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Radiation Therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: Patient must have up to 3 painful bone metastasis(-es) in the extremities
Exclusions: Patients with prior radiotherapy to the treatment site(s); Patients with more than 3 painful bone metastases of the limbs requiring palliative radiotherapy

Comments are closed.

Up ↑